Firm Advises Ayble Health on $16 Million Series A

September 24, 2026 - 00:37

On September 16, 2026, Ayble Health, a prominent AI-enabled virtual multidisciplinary GI clinic, announced the completion of a $16 million oversubscribed Series A funding round. The investment was led by Neon, with significant participation from other investors. This financial milestone marks a major step forward for the company as it seeks to transform the landscape of digestive health care.

The funding will support Ayble Health's mission to provide comprehensive, accessible care for individuals suffering from gastrointestinal conditions. By leveraging artificial intelligence, the clinic offers personalized treatment plans that connect patients with a multidisciplinary team of specialists. This approach aims to address the complex nature of GI disorders, which often require coordinated care across nutrition, psychology, and gastroenterology.

The oversubscribed round indicates strong investor confidence in the company's model and its potential for growth. Ayble Health plans to use the capital to expand its clinical operations, enhance its technology platform, and reach more patients nationwide. The company's focus on virtual care has become increasingly relevant as demand for remote healthcare services continues to rise.

This latest funding round positions Ayble Health to further innovate in the digestive health space and improve outcomes for patients seeking effective, integrated treatment options.